−2.06HKD
−848.63 MHKD
192.11 MHKD
380.85 M
About JW (CAYMAN) THERAPEUTICS CO. LTD
Sector
Industry
CEO
Yi Ping Li
Website
Headquarters
Shanghai
Employees (FY)
398
Founded
2017
ISIN
KYG5210T1040
FIGI
BBG00XXS5DK3
JW (Cayman) Therapeutics Co. Ltd. is a clinical stage cell therapy company, which focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. The company was founded by Yi Ping Li on September 6, 2017 and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2126 is 1.72 HKD — it has decreased by 3.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JW (CAYMAN) THERAPEUTICS CO. LTD stocks are traded under the ticker 2126.
JW (CAYMAN) THERAPEUTICS CO. LTD is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for JW (CAYMAN) THERAPEUTICS CO. LTD has a max estimate of 3.56 HKD and a min estimate of 2.20 HKD.
2126 earnings for the last quarter are −1.01 HKD whereas the estimation was −0.92 HKD which accounts for −9.41% surprise. Estimated earnings for the next quarter are −0.89 HKD. See more details about JW (CAYMAN) THERAPEUTICS CO. LTD earnings.
JW (CAYMAN) THERAPEUTICS CO. LTD revenue for the last quarter amounts to 94.82 M HKD despite the estimated figure of 177.35 M HKD. In the next quarter revenue is expected to reach 106.18 M HKD.
Yes, you can track JW (CAYMAN) THERAPEUTICS CO. LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 2126 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JW (CAYMAN) THERAPEUTICS CO. LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 398.00 employees. See our rating of the largest employees — is JW (CAYMAN) THERAPEUTICS CO. LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JW (CAYMAN) THERAPEUTICS CO. LTD EBITDA is −532.97 M HKD, and current EBITDA margin is −276.69%. See more stats in JW (CAYMAN) THERAPEUTICS CO. LTD financial statements.